Micellized protein transduction domain-bone morphogenetic protein-2 accelerates bone healing in a rat tibial distraction osteogenesis model
Acta Biomaterialia · 2023
DOI: 10.1016/j.actbio.2023.08.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2023. Verfasst von Cheol Hee Jeong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Pathology, Yonsei University College of Dentistry, Seoul, 03722, Korea; Oral Cancer Research Institute, Yonsei University College …. Hauptthemen laut MEDLINE: Osteogenesis, Distraction, Prodrugs. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Ministry of Science, ICT and Future Planning, National Research Foundation of Korea, Yonsei University College of Medicine.
Abstract (Originalsprache)
The clinical application of growth factors such as recombinant human bone morphogenetic protein-2 (rh-BMP-2), for functional bone regeneration remains challenging due to limited in vivo efficacy and adverse effects of previous modalities. To overcome the instability and short half-life of rh-BMP-2 in vivo, we developed a novel osteogenic supplement by fusing a protein transduction domain (PTD) with BMP-2, effectively creating a prodrug of BMP-2. In this study, we first created an improved PTD-BMP-2 formulation using lipid nanoparticle (LNP) micellization, resulting in downsizing from micrometer to nanometer scale and achieving a more even distribution. The micellized PTD-BMP-2 (mPTD-BMP-2) demonstrated improved distribution and aggregation profiles. As a prodrug of BMP-2, mPTD-BMP-2 successfully activated Smad1/5/8 and induced mineralization with osteogenic gene induction in vitro. In vivo pharmacokinetic analysis revealed that mPTD-BMP-2 had a much more stable pharmacokinetic profile than rh-BMP-2, with a 7.5-fold longer half-life. The in vivo BMP-responsive element (BRE) reporter system was also successfully activated by mPTD-BMP-2. In the in vivo rat tibia distraction osteogenesis (DO) model, micro-computed tomography (micro-CT) scan findings indicated that mPTD-BMP-2 significantly increased bone volume, bone surface, axis moment of inertia (MOI), and polar MOI. Furthermore, it increased the expression of osteogenesis-related genes, and induced bone maturation histologically. Based on these findings, mPTD-BMP-2 could be a promising candidate for the next-generation osteogenesis drug to promote new bone formation in DO surgery. STATEMENT OF SIGNIFICANCE: This study introduces micellized bone morphogenetic protein-2 (mPTD-BMP-2), a next-generation osteogenic supplement that combines protein transduction domain (PTD) and nano-sized micelle formulation technique to improve transduction efficiency and stability. The use of PTD represents a novel approach, and our results demonstrate the superiority of mPTD-BMP-2 over rh-BMP-2 in terms of in vivo pharmacokinetic profile and osteogenic potential, particularly in a rat tibial model of distraction osteogenesis. These findings have significant scientific impact and potential clinical applications in the treatment of bone defects that require distraction osteogenesis. By advancing the field of osteogenic supplements, our study has the potential to contribute to the development of more effective treatments for musculoskeletal disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Pathology, Yonsei University College of Dentistry, Seoul, 03722, Korea; Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, 03722, Korea.
- Department of Orthopedic Surgery, Asan Medical Center, Ulsan University College of Medicine, Seoul, 05505, Korea.
- MET Life Science, Seoul, 03722, Korea.
- Department of Advanced General Dentistry, Yonsei University College of Dentistry, Seoul, 03722, Korea.
- Department of Oral and Maxillofacial Surgery, Gangnam Severance Hospital, Yonsei University College of Dentistry, Seoul, 06273, Korea.
- Department of Oral Pathology, Yonsei University College of Dentistry, Seoul, 03722, Korea; Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, 03722, Korea; MET Life Science, Seoul, 03722, Kor…
Förderung
- Ministry of Science, ICT and Future Planning
- National Research Foundation of Korea
- Yonsei University College of Medicine
- Yonsei University College of Dentistry
Zitieren
APA
Jeong, C. H., Lim, S. Y., Um, J. E., Lim, H. W., Hwang, K. H., Park, K. M., Yun, J. S., Kim, D., Huh, J. K., Kim, H. S., Yook, J. I., Kim, N. H., & Kwak, Y. H. (2023). Micellized protein transduction domain-bone morphogenetic protein-2 accelerates bone healing in a rat tibial distraction osteogenesis model. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2023.08.031
Vancouver
Jeong CH, Lim SY, Um JE, Lim HW, Hwang KH, Park KM, et al. Micellized protein transduction domain-bone morphogenetic protein-2 accelerates bone healing in a rat tibial distraction osteogenesis model. Acta Biomaterialia. 2023. doi:10.1016/j.actbio.2023.08.031
BibTeX
@article{Jeong2023,
author = {Jeong, Cheol Hee and Lim, Song-Yi and Um, Jo Eun and Lim, Hyo Won and Hwang, Kyu Ho and Park, Kyeong-Mee and Yun, Jun Seop and Kim, Dohun and Huh, Jong-Ki and Kim, Hyun Sil and Yook, Jong In and Kim, Nam Hee and Kwak, Yoon Hae},
title = {Micellized protein transduction domain-bone morphogenetic protein-2 accelerates bone healing in a rat tibial distraction osteogenesis model},
journal = {Acta Biomaterialia},
year = {2023},
doi = {10.1016/j.actbio.2023.08.031}
}
EUVIMED